AVATAR therapy for auditory verbal hallucinations in people with psychosis: a single-blind, randomised controlled trial

被引:208
|
作者
Craig, Tom K. J. [1 ]
Rus-Calafell, Mar [1 ]
Ward, Thomas [2 ]
Leff, Julian P. [3 ]
Huckvale, Mark [4 ]
Howarth, Elizabeth [5 ]
Emsley, Richard [5 ]
Garety, Philippa A. [2 ]
机构
[1] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Hlth Serv & Populat Res, London SE5 8AF, England
[2] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol, London, England
[3] Royal Free & Univ Coll Med Sch, Dept Mental Hlth Sci, London, England
[4] UCL, Dept Speech Hearing & Phonet Sci, London, England
[5] Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Hlth Sci, Ctr Biostat, Manchester, Lancs, England
来源
LANCET PSYCHIATRY | 2018年 / 5卷 / 01期
基金
英国惠康基金;
关键词
COGNITIVE-BEHAVIORAL THERAPY; SYMPTOM RATING-SCALES; ASSISTED THERAPY; VOICES; SCHIZOPHRENIA; INTERVENTIONS; OMNIPOTENCE; DEPRESSION; DIMENSIONS; DELUSIONS;
D O I
10.1016/S2215-0366(17)30427-3
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background A quarter of people with psychotic conditions experience persistent auditory verbal hallucinations, despite treatment. AVATAR therapy (invented by Julian Leff in 2008) is a new approach in which people who hear voices have a dialogue with a digital representation (avatar) of their presumed persecutor, voiced by the therapist so that the avatar responds by becoming less hostile and concedes power over the course of therapy. We aimed to investigate the effect of AVATAR therapy on auditory verbal hallucinations, compared with a supportive counselling control condition. Methods We did this single-blind, randomised controlled trial at a single clinical location (South London and Maudsley NHS Trust). Participants were aged 18 to 65 years, had a clinical diagnosis of a schizophrenia spectrum (ICD10 F20-29) or affective disorder (F30-39 with psychotic symptoms), and had enduring auditory verbal hallucinations during the previous 12 months, despite continued treatment. Participants were randomly assigned (1: 1) to receive AVATAR therapy or supportive counselling with randomised permuted blocks (block size randomly varying between two and six). Assessments were done at baseline, 12 weeks, and 24 weeks, by research assessors who were masked to therapy allocation. The primary outcome was reduction in auditory verbal hallucinations at 12 weeks, measured by total score on the Psychotic Symptoms Rating Scales Auditory Hallucinations (PSYRATS-AH). Analysis was by intention-totreat with linear mixed models. The trial was prospectively registered with the ISRCTN registry, number 65314790. Findings Between Nov 1, 2013, and Jan 28, 2016, 394 people were referred to the study, of whom 369 were assessed for eligibility. Of these people, 150 were eligible and were randomly assigned to receive either AVATAR therapy (n=75) or supportive counselling (n=75). 124 (83%) met the primary outcome. The reduction in PSYRATS-AH total score at 12 weeks was significantly greater for AVATAR therapy than for supportive counselling (mean difference -3.82 [SE 1.47], 95% CI-6.70 to -0.94; p<0.0093). There was no evidence of any adverse events attributable to either therapy. Interpretation To our knowledge, this is the first powered, randomised controlled trial of AVATAR therapy. This brief, targeted therapy was more effective after 12 weeks of treatment than was supportive counselling in reducing the severity of persistent auditory verbal hallucinations, with a large effect size. Future multi-centre studies are needed to establish the effectiveness of AVATAR therapy and, if proven effective, we think it should become an option in the psychological treatment of auditory verbal hallucinations. Copyright (C) The Author(s). Published by Elsevier Ltd.
引用
收藏
页码:31 / 40
页数:10
相关论文
共 50 条
  • [21] Targeted physiotherapy for patellofemoral joint osteoarthritis: A protocol for a randomised, single-blind controlled trial
    Crossley, Kay M.
    Vicenzino, Bill
    Pandy, Marcus G.
    Schache, Anthony G.
    Hinman, Rana S.
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2008, 9 (1)
  • [22] A single-blind randomised controlled trial of a topical kanuka honey formulation for the treatment of acne
    Holt, S.
    Beasley, R.
    Weatherall, M.
    Braithwaite, I.
    Holliday, M.
    Montgomery, B.
    Corin, A.
    Helm, C.
    Sheahan, D.
    Tofield, C.
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2015, 56 (04) : A5 - A5
  • [23] The effect of staff training on the use of restraint in dementia: A single-blind randomised controlled trial
    Testad, I
    Aarsland, D
    Aasland, AM
    [J]. NEUROBIOLOGY OF AGING, 2002, 23 (01) : S46 - S46
  • [24] The effect of staff training on the use of restraint in dementia: a single-blind randomised controlled trial
    Testad, I
    Aasland, AM
    Aarsland, D
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2005, 20 (06) : 587 - 590
  • [25] Targeted physiotherapy for patellofemoral joint osteoarthritis: A protocol for a randomised, single-blind controlled trial
    Kay M Crossley
    Bill Vicenzino
    Marcus G Pandy
    Anthony G Schache
    Rana S Hinman
    [J]. BMC Musculoskeletal Disorders, 9
  • [26] Progressive resistance training and dynamic alignment in osteoarthritis: A single-blind randomised controlled trial
    Foroughi, Nasim
    Smith, Richard M.
    Lange, Angela K.
    Singh, Maria A. Fiatarone
    Vanwanseele, Benedicte
    [J]. CLINICAL BIOMECHANICS, 2011, 26 (01) : 71 - 77
  • [27] Cognitive therapy for command hallucinations: randomised controlled trial
    Trower, P
    Birchwood, M
    Meaden, A
    Byrne, S
    Nelson, A
    Ross, K
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2004, 184 : 312 - 320
  • [28] Efficacy of bilateral continuous theta burst stimulation in treatment resistant auditory hallucinations: a single-blind, randomized, sham-controlled trial.
    Purohith, A.
    Kumar, C.
    Mehta, U.
    [J]. EUROPEAN PSYCHIATRY, 2020, 63 : S497 - S498
  • [29] Treating sleep problems in young people at ultra-high-risk of psychosis: study protocol for a single-blind parallel group randomised controlled feasibility trial (SleepWell)
    Waite, Felicity
    Kabir, Thomas
    Johns, Louise
    Mollison, Jill
    Tsiachristas, Apostolos
    Petit, Ariane
    Cernis, Emma
    Maughan, Daniel
    Freeman, Daniel
    [J]. BMJ OPEN, 2020, 10 (11):
  • [30] Avatar Therapy for Persistent Auditory Verbal Hallucinations in an Ultra-Resistant Schizophrenia Patient: A Case Report
    Dellazizzo, Laura
    Potvin, Stephane
    Phraxayavong, Kingsada
    Lalonde, Pierre
    Dumais, Alexandre
    [J]. FRONTIERS IN PSYCHIATRY, 2018, 9